-
Nafamostat mesylate (INN), a
synthetic serine protease inhibitor, is a short-acting anticoagulant, and it is also used for the
treatment of pancreatitis...
-
nadolol (INN)
nadoxolol (INN)
nadroparin calcium (INN) na****rel (INN)
nafamostat (INN)
nafarelin (INN)
Nafazair (Bausch & Lomb)
nafazatrom (INN) nafcaproic...
- hydroxychloroquine,
interferon β-1a, and colchicine. As of 2021,
favipiravir and
nafamostat had
shown mixed results but were
still in
clinical trials in some countries...
- some
medications used to
treat the
infection with SARS-CoV-2,
namely Nafamostat and Azithromycin,
ended up
promoting the
production of
mature virions...
- PMID 16335799. S2CID 6258657.
Yamaori S,
Ukena E,
Fujiyama N, et al. (2007). "
Nafamostat is
hydrolysed by
human liver cytosolic long-chain acyl-CoA hydrolase"...
- TMPRSS2-inhibitors
Camostat and, in a
second report by
other researchers on 18 March,
Nafamostat may be
potential treatments as they
reduced the
probability of the virus...
- non-selective
inhibitor of cysteine, serine, and
threonine proteases Nafamostat -
inhibitor of trypsin, tryptase, and
various other serine proteases Pacifastins...
